Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: J Invest Dermatol. 2015 Mar 3;135(7):1905–1908. doi: 10.1038/jid.2015.65

Table 1.

Clinical features and CARD14 variants in patients with sporadic PRP1

Variant2 Age (Y)/Sex Age at onset/diagnosis (Y) Duration (Y) Type3 SNP rs Variant Minor allele frequency (%) Functional consequences on the protein (Bioinformatics prediction programs)
Polyphen-2 SIFT PMut SNAP PROVEAN
1a 72/F 47/57 20 2 rs114688446 c.599G>A, p.S200N A: 0.8 Benign Tolerated Neutral Neutral Neutral
b 56/M 51/51 2 1
c 62/M 57/57 3 1
2 75/M 70/70 2 1 rs142246283 c.683T>G, p.L228R no data Probably damaging Tolerated Pathological Neutral Neutral
3 46/F 21/21 2 1 rs117918077 c.2044C>T, p.R682W T: 1.2 Probably damaging Damaging Pathological Non-neutral Deleterious
4 35/F 32/32 1 1 no data c.2406C>A, p.S802R no data Benign Damaging Pathological Neutral Neutral
1

A total of 15 genomic variants were identified in the CARD14 gene in 48 patients with sporadic PRP (Table S1). The above variants have minor allele frequency of less than 1.5%

2

Note that the Variant 1 was disclosed in three different families (a–c)

3

Type 1: Classic adult type; Type 2: Atypical presentation with prolonged manifestations